TrialPloS one2022

Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial.

Westyn Branch-Elliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.